Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer.
Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions.
Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.
Crizotinib in ROS1-rearranged non-small-cell lung cancer.
Correction: Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Correction: Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer.
Correction: Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer. Mol Cancer Ther. 2022 Apr 01; 21(4):700.
View in:
PubMed
authors with profiles
Ravi Salgia